URGN logo

UroGen Pharma (URGN) Enterprise Value

Enterprise Value

$425.12 M
-$1.05 M-0.25%

9 min ago


Summary


Performance

URGN Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherURGNvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

URGN Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-0.3%-0.3%-0.3%
1 m1 month-7.0%-6.9%-6.9%
3 m3 months-17.6%-17.4%-17.4%
6 m6 months-2.4%-23.2%-23.3%
ytdytd-6.2%-6.2%-6.2%
1 y1 year-28.1%-27.0%-43.8%
5 y5 years-25.3%-30.5%-65.2%

URGN Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-12.9%$388 M+9.5%
3 m3-month$518 M-18.0%$388 M+9.5%
6 m6-month$558 M-23.8%$388 M+9.5%
1 y1-year$677 M-37.2%$388 M+9.5%
3 y3-year$780 M-45.5%$82 M+419.2%
5 y5-year$780 M-45.5%$82 M+419.2%
alltimeall time$883 M-51.9%$82 M+419.2%

UroGen Pharma Enterprise Value History

DateValue
2025
$425.12 M(-6.2%)
2024
$453.18 M(-7.8%)
2023
$491.74 M(+97.6%)
2022
$248.88 M(+46.7%)
DateValue
2021
$169.66 M(-51.3%)
2020
$348.10 M(-46.8%)
2019
$654.56 M(+9.7%)
2018
$596.90 M(+25.7%)
2017
$474.69 M

FAQ

  • What is UroGen Pharma enterprise value?
  • What is the all time high enterprise value for UroGen Pharma?
  • What is URGN enterprise value year-to-date change?
  • What is UroGen Pharma enterprise value year-on-year change?

What is UroGen Pharma enterprise value?

The current enterprise value of URGN is $425.12 M

What is the all time high enterprise value for UroGen Pharma?

UroGen Pharma all-time high enterprise value is $883.46 M

What is URGN enterprise value year-to-date change?

UroGen Pharma enterprise value has changed by -$28.06 M (-6.19%) since the beginning of the year

What is UroGen Pharma enterprise value year-on-year change?

Over the past year, URGN enterprise value has changed by -$165.72 M (-28.05%)